JP2007509155A5 - - Google Patents

Download PDF

Info

Publication number
JP2007509155A5
JP2007509155A5 JP2006536758A JP2006536758A JP2007509155A5 JP 2007509155 A5 JP2007509155 A5 JP 2007509155A5 JP 2006536758 A JP2006536758 A JP 2006536758A JP 2006536758 A JP2006536758 A JP 2006536758A JP 2007509155 A5 JP2007509155 A5 JP 2007509155A5
Authority
JP
Japan
Prior art keywords
dosage form
quetiapine
hours
oral cavity
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006536758A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007509155A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/034743 external-priority patent/WO2005041935A1/en
Publication of JP2007509155A publication Critical patent/JP2007509155A/ja
Publication of JP2007509155A5 publication Critical patent/JP2007509155A5/ja
Pending legal-status Critical Current

Links

JP2006536758A 2003-10-21 2004-10-21 クエチアピンを含有する薬剤 Pending JP2007509155A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51346103P 2003-10-21 2003-10-21
PCT/US2004/034743 WO2005041935A1 (en) 2003-10-21 2004-10-21 Pharmaceutical formulations containing quetiapine

Publications (2)

Publication Number Publication Date
JP2007509155A JP2007509155A (ja) 2007-04-12
JP2007509155A5 true JP2007509155A5 (cg-RX-API-DMAC7.html) 2007-11-22

Family

ID=34549280

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006536758A Pending JP2007509155A (ja) 2003-10-21 2004-10-21 クエチアピンを含有する薬剤

Country Status (7)

Country Link
US (2) US20050158383A1 (cg-RX-API-DMAC7.html)
EP (1) EP1689367A1 (cg-RX-API-DMAC7.html)
JP (1) JP2007509155A (cg-RX-API-DMAC7.html)
CN (1) CN101005829A (cg-RX-API-DMAC7.html)
CA (1) CA2542836A1 (cg-RX-API-DMAC7.html)
IS (1) IS8460A (cg-RX-API-DMAC7.html)
WO (1) WO2005041935A1 (cg-RX-API-DMAC7.html)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050171088A1 (en) * 2004-01-30 2005-08-04 Astrazeneca Ab Treatment of psychoses with dibenzothiazepine antipsychotic
WO2006081347A2 (en) * 2005-01-26 2006-08-03 Elan Pharma International Limited Controlled release compositions comprising an antipsychotic agent
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
DK1808164T3 (da) 2006-01-05 2009-04-20 Teva Pharma Vådgranuleringsmetode til fremstilling af farmaceutiske sammensætninger af aripiprazol
EP1976487A2 (en) * 2006-01-25 2008-10-08 Astron Research Limited Sustained release dosage form of phenothiazine derivatives containing channelizer
DE102006033723A1 (de) * 2006-07-21 2008-01-24 Bayer Technology Services Gmbh Formulierungen von Multikompartimenten-Granulaten für Wirkstoffe
WO2008012346A1 (en) * 2006-07-28 2008-01-31 Farmaprojects, S. A. Extended release pharmaceutical formulation of metoprolol and process for its preparation
GB0618879D0 (en) * 2006-09-26 2006-11-01 Zysis Ltd Pharmaceutical compositions
US8623861B2 (en) * 2006-11-03 2014-01-07 Xin-Min Li Method of treating demyelination diseases
PT103884A (pt) * 2006-11-17 2008-05-19 Astrazeneca Ab Composições de libertação prolongada e métodos para a sua preparação
EP1958617B1 (en) * 2007-02-14 2010-09-08 Laboratorios Lesvi, S.L. Pharmaceutical compositions containing quetiapine fumarate
EP2131817A2 (en) * 2007-03-09 2009-12-16 Synthon B.V. Pharmaceutical composition of quetiapine fumarate
EP1970056A1 (en) * 2007-03-15 2008-09-17 Polichem S.A. Time-specific delayed/pulsatile release dosage forms
US20090035370A1 (en) * 2007-08-02 2009-02-05 Drugtech Corporation Dosage form and method of use
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090143343A1 (en) * 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
DK3354276T3 (da) 2007-11-13 2020-03-30 Meritage Pharma Inc Sammensætninger til behandlingen af gastrointestinal inflammation
US20090148532A1 (en) * 2007-12-06 2009-06-11 Venkatesh Gopi M Preparation of controlled release skeletal muscle relaxant dosage forms
US20090220593A1 (en) * 2008-01-29 2009-09-03 Gulati Inder Extended release dosage forms of quetiapine
EP2268283A2 (en) * 2008-03-12 2011-01-05 Dexcel Ltd. Oral modified-release formulations containing thiazepines
AU2009265099A1 (en) * 2008-07-01 2010-01-07 Lupin Limited Sustained release pharmaceutical compositions comprising Quetiapine
AU2009270823B2 (en) 2008-07-16 2014-07-17 Richter Gedeon Nyrt. Pharmaceutical formulations containing dopamine receptor ligands
EP2299983A4 (en) * 2008-07-24 2012-10-10 Handa Pharmaceuticals Llc ATYPICAL ANTIPSYCHOTIC FORMULATION STABILIZED
DE202009018024U1 (de) 2008-08-01 2010-12-09 Krka Tovarna Zdravil, D.D., Novo Mesto Quetiapin-Zusammensetzung
EP2153834A3 (en) * 2008-08-07 2010-02-24 Farmaprojects, S.A. Extended release pharmaceutical compositions comprising quetiapine salts
AU2009289464B2 (en) * 2008-09-04 2015-12-10 Farnam Companies, Inc. Chewable sustained release formulations
DE102008046650A1 (de) 2008-09-10 2010-03-11 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Quetiapin enthaltende Retardtablette
WO2010066342A1 (en) * 2008-11-26 2010-06-17 Krka Quetiapine composition
WO2010082220A2 (en) * 2009-01-05 2010-07-22 Torrent Pharmaceuticals Limited Sustained release pharmaceutical composition of quetiapine and process for preparation thereof
WO2010089259A2 (en) 2009-02-04 2010-08-12 Woerwag R&D Gmbh Sustained release composition containing quetiapine
EP2233130A1 (en) * 2009-03-23 2010-09-29 Genepharm (Europe) Trading Limited A sustained release oral composition of an antipsychotic agent
EP2440210A4 (en) * 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
CN107714703A (zh) 2009-12-31 2018-02-23 凯姆制药公司 喹硫平的氨基酸缀合物、其制备和使用方法
WO2011103718A1 (zh) * 2010-02-26 2011-09-01 上海沪美医药科技有限公司 一种含有喹硫平的控(缓)释制剂及其制备方法和用途
EP2544667B1 (en) * 2010-03-09 2018-11-14 Alkermes Pharma Ireland Limited Alcohol resistant enteric pharmaceutical compositions
RS58335B1 (sr) 2010-03-11 2019-03-29 Kempharm Inc Konjugati kvetiapina sa masnom kiselinom, proces za njihovo dobijanje i njihova primena
EP2588089B1 (en) 2010-04-07 2017-08-30 Kemin Industries, Inc. Micro particles for oral delivery in animals
WO2011132008A2 (en) 2010-04-22 2011-10-27 EGIS Gyűgyszergyár Nyilvánosan Múködő Részvény társaság Controlled release pharmaceutical composition
CA2705685A1 (en) * 2010-05-27 2011-11-27 Pharmascience Inc. Pharmaceutical dosage form containing an antipsychotic agent
WO2011154118A1 (en) * 2010-06-07 2011-12-15 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Quetiapine prolonged-release tablets
DE102010033527A1 (de) 2010-08-05 2012-02-09 Acino Pharma Ag Quetiapin-Tabletten
TR201008261A1 (tr) * 2010-10-08 2012-04-24 Sanovel İlaç San. Ve Ti̇c. A.Ş. Kontrollü salım gerçekleştiren ketiapin formülasyonları
CN102525988B (zh) * 2011-01-04 2016-01-06 北京天衡药物研究院 富马酸喹硫平缓释片
AT511581A1 (de) * 2011-05-26 2012-12-15 G L Pharma Gmbh Orale retardierende formulierung
DE102011115690A1 (de) 2011-10-11 2013-04-11 Acino Pharma Ag Quetiapin enthaltende Formulierungen
WO2013100879A1 (en) * 2011-12-27 2013-07-04 Mahmut Bilgic Pharmaceutical compositions comprising quetiapine
CN103211794A (zh) * 2012-01-18 2013-07-24 北京天衡药物研究院 富马酸喹硫平膜控缓释微丸胶囊
US8912197B2 (en) 2012-08-20 2014-12-16 Forest Laboratories Holdings Ltd. Crystalline form of carbamoyl-cyclohexane derivatives
US20150231080A1 (en) 2012-09-10 2015-08-20 Pharmathen S.A. Pharmaceutical composition comprising an atypical antipsychotic agent and method for the preparation thereof
WO2014155387A1 (en) * 2013-03-24 2014-10-02 Tushar Patel Extended release dosage forms of quetiapine salts
US20160199369A1 (en) * 2013-08-12 2016-07-14 Pharmaceutical Manufacturing Research Services, Inc. Extruded Immediate Release Abuse Deterrent Pill
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
DK3169315T3 (da) 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
GB201420311D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Pharmaceutical processing
GB201420300D0 (en) * 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Tablet
GB201420306D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Compositions
CN104523600A (zh) * 2014-11-21 2015-04-22 哈尔滨圣吉药业股份有限公司 一种富马酸喹硫平缓释微丸及其制备方法
CN104546800A (zh) * 2015-01-07 2015-04-29 万特制药(海南)有限公司 一种富马酸喹硫平缓释胶囊及其制备方法
RU2588840C1 (ru) * 2015-03-26 2016-07-10 Общество с ограниченной ответственностью ООО "ВАЛЕНТА-ИНТЕЛЛЕКТ" Таблетки кветиапина с пролонгированным высвобождением и способ их получения
US20190022013A1 (en) 2015-12-19 2019-01-24 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
CN108712900A (zh) * 2015-12-19 2018-10-26 第时间美国泛型药物有限公司 软咀嚼片剂药物制剂
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
US9993486B1 (en) 2017-06-19 2018-06-12 Tlc Therapeutics, Llc Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailability
WO2020025579A1 (en) * 2018-07-31 2020-02-06 Medichem, S.A. Solid dosage form of quetiapine fumarate
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
EP4213817A1 (en) * 2020-09-21 2023-07-26 Sun Pharmaceutical Industries Limited Multi-particulate pharmaceutical composition of quetiapine
US12251208B2 (en) * 2020-11-30 2025-03-18 International Business Machines Corporation Time controlled medication
WO2024086307A1 (en) * 2022-10-19 2024-04-25 Vitakey Inc. Formulated food products
CN120114403B (zh) * 2025-03-12 2025-12-02 上海国创医药股份有限公司 一种富马酸喹硫平缓释组合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
JP3628401B2 (ja) * 1995-11-09 2005-03-09 信越化学工業株式会社 無溶媒腸溶性コーティング剤された腸溶性製剤
US20030059471A1 (en) * 1997-12-15 2003-03-27 Compton Bruce Jon Oral delivery formulation
DE69915346T2 (de) * 1998-12-17 2004-07-22 Alza Corp., Mountain View Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen
WO2003039514A1 (en) * 2001-10-18 2003-05-15 Verion Inc. Microcapsule matrix microspheres, absorption-enhancing pharmaceutical compositions and methods
US20030158254A1 (en) * 2002-01-24 2003-08-21 Xenoport, Inc. Engineering absorption of therapeutic compounds via colonic transporters

Similar Documents

Publication Publication Date Title
US7094427B2 (en) Combination immediate release controlled release levodopa/carbidopa dosage forms
ES2300845T5 (es) Procedimiento para la fabricación de una composición farmacéutica sólida de administración oral con 5-cloro-N({(5-2-oxo-3-[4-(3-oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofenocarboxamida
CN100415223C (zh) 缓释的口服给药组合物
US20120301541A1 (en) Compressed core for pharmaceutical composition
EP2373319B1 (en) Sustained release pharmaceutical composition of quetiapine and process for preparation thereof
JP6759426B2 (ja) Cns化合物の安定化製剤
MXPA96005646A (en) Preparation of nifedipine of release prolong
EP1507518B1 (en) Combination immediate release controlled release levodopa/carbidopa dosage forms
HUP0104318A2 (hu) cGMP PDE-5 inhibitort tartalmazó szabályzottan hatóanyagot felszabadító gyógyászati készítmények
JP2020523335A5 (cg-RX-API-DMAC7.html)
RU2015107517A (ru) Фармацевтические композиции мемантина
EP3463289B1 (en) Process for the preparation of drug delivery systems having a testosterone compound present in an outer layer or part, as well as such drug delivery systems
JP2019529570A (ja) ミドドリンの組成物およびその使用方法
JP2007507491A (ja) 徐放性製剤
KR20070069105A (ko) 서방성 제제
US20090220593A1 (en) Extended release dosage forms of quetiapine
US20140010883A1 (en) Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor
JP2024519917A5 (cg-RX-API-DMAC7.html)
US20090264460A1 (en) Clopidogrel pharmaceutical formulations
EP3331502B1 (en) Controlled release propiverine formulations
KR101345468B1 (ko) 졸피뎀 정제
EA011579B1 (ru) Композиция с пролонгированным высвобождением венлафаксина
WO2007132344A2 (en) Controlled release compositions of an antidepressant agent
KR101118866B1 (ko) 박동성 방출 제제 및 그 제조방법
KR20090107960A (ko) 심혈관계 질환 치료용 약제학적 제제